RestorGenex Corporation and Diffusion Pharmaceuticals have formed a merger agreement under which a newly formed subsidiary of RestorGenex will merge with and into Diffusion, which will become a wholly owned subsidiary of RestorGenex. The current directors and executive officers of RestorGenex will resign from their positions and the combined company will be under the leadership of Diffusion’s current executive management team with David Kalergis serving as chief executive officer. The c...